• 阳性阴性症状量表PANSS评定临床疗效,以副反应量表(TESS)评定不良反应。

    The efficacy was evaluated by positive and negative symptom scale(PANSS), and the side effects by treatment emergent symptom scale(TESS).

    youdao

  • 方法采用随机对照方法,马普替林为对照组,应用HAMDHAMATESS量表疗前、疗1246进行疗效副反应评定。

    Methods the patients were randomly assigned into venlafaxine and maprotiline group and tested with HAMD, HAMA and TESS at the time of weeks 1, 2, 4, 6 weeks after treatment.

    youdao

  • 治疗,治疗4812周末分别阻性症状阴性症状量表PANSS)和副反应量表TESS)评定疗效副作用

    The efficiency and side effects were assessed with the postive and negative symptom scale (PANSS)and treatment emergent symptom seale (TESS) before and 4,8and 12 weekends after the treatment.

    youdao

  • 采用阳性症状量表阴性症状量表(PANSS)评定齐拉西酮对女性精神分裂症的疗效,采用不良反应量表(TESS)评定该药物的副反应

    The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.

    youdao

  • 采用阳性症状量表阴性症状量表(PANSS)评定齐拉西酮对女性精神分裂症的疗效,采用不良反应量表(TESS)评定该药物的副反应

    The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定